Specialty insurer and reinsurer covering energy, property, casualty and financial lines internationally, based in Bermuda.
Specialty insurer and reinsurer covering energy, property, casualty and financial lines internationally, based in Bermuda.
Underwrites risks that are hard to place elsewhere, such as energy, political violence and marine, and earns premiums less claims and costs, plus investment income on premiums held before claims are paid. Its main office is in Amman, Jordan, with underwriting hubs in London and Bermuda.
Moat: narrow (process know-how, regulatory licence). Underwriting expertise in niche specialty/energy risks across emerging markets that generalist insurers avoid.
Headquarters: Amman, Jordan · Founded: 2001 · Employees: 484
Size International General Insurance (IGIC) is a United States Financials company (Financial Conglomerates) with a market value of $1.01B, the 2227th largest of 3,085 United States companies the cockpit tracks. Shares closed at $23.90 on 18 Nov 2026.
Performance Over six months the shares fell 5.5%, against +1.6% for the median peer and -2.2% for the United States market (cap-weighted) — 9th lowest of 21 in its peer set.
Growth Revenue grew 2.0% over the last twelve months (peer median +1.7%); the operating margin is 20.2% (peer median 15.0%).
Valuation It trades at 1.52× book value against a peer median of 1.14× (7th most expensive of 20).
Price implies The share price implies a return on equity of about 8.4%; International General Insurance delivers 15.2%, so the price asks less than the business earns today.
Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $536M | $517M | $534M | $472M | $398M |
| Revenue growth | — | -3% | +13% | +18% | — |
| Net income | $103M | $126M | $133M | $111M | $84.2M |
| Free cash flow | n/a | $107M | $203M | $193M | $154M |
| Capital expenditure | n/a | $944,000 | $6.63M | $77.0M | $1.27M |
| Total debt | n/a | $1.56M | $4.24M | $2.13M | $2.66M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE |
|---|---|---|---|---|---|---|
| International General Insurance IGIC | $1.01B | -5% | +2% | 15% | 1.52× | 8.4% |
| Lancashire LRE.L | $2.08B | +2% | -2% | 22% | 1.41× | 12.4% |
| Arch Capital ACGL | $35.4B | +12% | -5% | 19% | 1.60× | 8.7% |
| RenaissanceRe RNR | $14.0B | +14% | -21% | 13% | 1.34× | 7.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | IGIC | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -3.7% | +0.8% | 5th lowest of 21 |
| 6-month return | -5.5% | +1.6% | 9th lowest of 21 |
| Return on equity | 15.2% | 6.0% | 6th highest of 19 |
| Price / book | 1.52× | 1.14× | 7th most expensive of 20 |
| Trailing P/E | 10.0× | 13.6× | 6th cheapest of 14 |
| ROE the price implies | 8.4% | 7.8% | 9th most demanding of 19 |
| ROE delivered | 15.2% | 6.5% | 6th highest of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| International General Insurance IGIC | United States | $1.01B | -5% | +2% | 15% | 1.52× | 8.4% | 15.2% |
| Mbb MBB.DE | Germany | $968M | +11% | 0% | 8% | 1.48× | 12.2% | 7.7% |
| Pacific Century Regional Developments P15.SI | Singapore | $965M | 0% | -37% | -17% | 193.75× | n/a | n/a |
| Next Generation Technology 319A.T | Japan | $1.09B | +62% | +35% | 50% | 15.35× | 153.5% | 49.8% |
| L1 Gold Fund LGF.AX | Australia | $926M | +11% | n/a | n/a | 1.18× | 16.9% | n/a |
| Morgan Stanley Direct Lending Fund MSDL | United States | $1.12B | -10% | -28% | 0% | 0.72× | 6.8% | 0.3% |
| KB Balhae Infrastructure Fund 415640.KS | South Korea | $911M | +1% | n/a | n/a | n/a | n/a | n/a |
| LunR Royalties LUNR.TO | Canada | $1.14B | -37% | n/a | -1% | 1.72× | 22.5% | -0.8% |
| Monex 8698.T | Japan | $884M | -14% | +4% | 4% | 1.14× | 8.5% | 4.0% |
| Jefferson Capital JCAP | United States | $1.21B | +22% | +64% | 32% | 2.34× | 11.3% | 31.9% |
| MidCap Financial Investment MFIC | United States | $822M | -7% | -4% | -6% | 0.78× | 7.1% | -6.1% |
| Viel & Cie VIL.PA | France | $1.30B | +5% | +6% | 23% | 2.01× | 10.9% | 23.1% |
| Patrizia PAT.DE | Germany | $765M | +6% | +19% | 2% | 0.62× | 6.1% | n/a |
| Ratos RATO-A.ST | Sweden | $1.35B | +19% | -23% | -2% | 0.91× | 7.4% | -1.6% |
| Senvest Capital SEC.TO | Canada | $745M | +21% | -17% | 20% | 0.42× | 4.2% | 20.5% |
| Peugeot Invest PEUG.PA | France | $1.46B | -13% | -101% | 6% | 0.37× | 6.4% | 6.3% |
| Hyosung 004800.KS | South Korea | $1.47B | -54% | +6% | 20% | 0.73× | 7.9% | 20.1% |
| Yangzijiang Maritime Development 8YZ.SI | Singapore | $1.50B | -13% | +18% | 7% | 0.90× | 3.6% | 6.9% |
| Bain Capital Specialty Finance BCSF | United States | $684M | -20% | -8% | 6% | 0.64× | 6.4% | 5.6% |
| Svolder SVOL-A.ST | Sweden | $667M | +42% | +1,360% | 7% | 1.80× | 11.5% | 6.8% |
| Drugs Made In America Acquisition II DMII | United States | $652M | +2% | n/a | 4% | 1.30× | 7.6% | 3.6% |